Know Cancer

or
forgot password

Pemetrexed Monochemotherapy in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer. A Pilot Study to Define the Best Dosing Schedule for a Planned Phase II Randomized Trial


Phase 2
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

Pemetrexed Monochemotherapy in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer. A Pilot Study to Define the Best Dosing Schedule for a Planned Phase II Randomized Trial

Inclusion Criteria


Inclusion Criteria

- Histologically or cytologically proven IIIB and IV NSCLC.

- No symptomatic uncontrolled brain metastasis

- Not suitable for platinum containing regimens if chemo-naive

- Performance status less than or equal to 2 on the Eastern Cooperative Oncology Group
(ECOG) Scale.

- Creatinine Clearance (CrCl) greater than or equal to 45 milliliters per min (mL/min)

Exclusion Criteria

- Prior radiation to greater than 25% of bone marrow

- Inability to interrupt Aspirin at doses of greater than 1.3 grams/day or
non-steroidal anti-inflammatory agents for a 5-day period.

- Presence of clinically relevant third-space fluid collections not controllable.

- Significant cardiac disease

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Mean Deoxycytidine Kinase (dCK) Expression Evaluated at Cycle 1, Cycle 2, and Cycle 3

Outcome Time Frame:

pre-dose, 1, 2, 4, 6, 24, and 48 hours post-dose (3 cycles)

Safety Issue:

No

Principal Investigator

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)

Investigator Role:

Study Director

Investigator Affiliation:

Eli Lilly and Company

Authority:

Italy: Ministry of Health

Study ID:

10940

NCT ID:

NCT00370292

Start Date:

September 2006

Completion Date:

September 2008

Related Keywords:

  • Non Small Cell Lung Cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location